MedPath

上海欣峰制药有限公司

Ownership
-
Established
2013-10-29
Employees
-
Market Cap
-
Website
https://www.shxfzhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

40

NMPA:40

Drug Approvals

Cefoxitin Sodium for Injection

Product Name
注射用头孢西丁钠
Approval Number
国药准字H20194055
Approval Date
Apr 9, 2024
NMPA

Cefoxitin Sodium for Injection

Product Name
注射用头孢西丁钠
Approval Number
国药准字H20237115
Approval Date
Apr 9, 2024
NMPA

Cefoxitin Sodium for Injection

Product Name
注射用头孢西丁钠
Approval Number
国药准字H20194054
Approval Date
Apr 7, 2024
NMPA

Cefpirome Sulfate for Injection

Product Name
注射用硫酸头孢匹罗
Approval Number
国药准字H20194024
Approval Date
Feb 27, 2024
NMPA

Ceftazidime and Avibactam Sodium for Injection

Product Name
注射用头孢他啶阿维巴坦钠
Approval Number
国药准字H20243177
Approval Date
Feb 6, 2024
NMPA

Ceftazidime for Injection

Product Name
注射用头孢他啶
Approval Number
国药准字H20237143
Approval Date
Nov 2, 2023
NMPA

Cefonicid Sodium for Injection

Product Name
注射用头孢尼西钠
Approval Number
国药准字H20190003
Approval Date
Oct 7, 2023
NMPA

Cefonicid Sodium for Injection

Product Name
注射用头孢尼西钠
Approval Number
国药准字H20190004
Approval Date
Oct 7, 2023
NMPA

Cefonicid Sodium for Injection

Product Name
注射用头孢尼西钠
Approval Number
国药准字H20190002
Approval Date
Oct 7, 2023
NMPA

Ceftriaxone Sodium for Injection

Product Name
注射用头孢曲松钠
Approval Number
国药准字H20237072
Approval Date
Jul 4, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.